Fundamentals

Valuation

Metric	Q3	Q1	Δ in %
EV/EBITDA	45.90	-25.62	-47.35
Graham Fair Price	-10.78	11.00	12.33
PEG	2019.86	-0.11	< 0.005
Price/Book	2.70	3.71	3.61
Price/Cash Flow	-18.41	-43.89	-37.06
Prices/Earnings	-6.10	-8.70	-8.20
Price/Sales	8.89	52.01	47.76
Price/FCF	-18.41	-43.89	-37.06
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q1	Δ in %
Gross Profit Margin	-7.05	0.52	0.56
Operating Margin	-39.58	-1.84	-1.32
ROA	5.03	-0.07	-0.08
ROE	-0.11	-0.11	3.20
ROIC	-0.07	-0.11	-62.67
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q1	Δ in %
Debt QOQ	-0.02	0.06	-75.97
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.08	-1.28	1479.71
EPS QOQ	-15.33	-0.77	94.99
FCF QOQ	-1.63	-0.09	94.25
Revenue QOQ	0.21	-0.51	141.40
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-58.26	< 0.005	-100.00
Days Sales Outstanding (DSO)	67.94	112.19	65.11
Inventory Turnover	-1.54	17708000.00	1146202351.14
Debt/Capitalization	0.19	0.20	5.69
Quick Ratio	5.03	4.48	-11.03
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q1	Δ in %
Book Value	7.84	7.11	-9.31
Cash	6.90	5.96	-13.58
Capex	-0.07	-0.06	17.14
Free Cash Flow	-0.76	-0.60	21.34
Revenue	0.59	0.51	-14.46
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q1	Δ in %
Current Ratio	5.21	4.64	-11.12
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.98	0.06	-98.04
Naive Interpretation	Member

06 - Financial Health · Bad

Rating